Bank J. Safra Sarasin has fully acquired the Zurich asset manager MIV Asset Management. The company serves as the portfolio manager for the MIV Global Medtech Fund.

The acquisition highlights J. Safra Sarasin's commitment to growth in Asset Management with its thematic equity investing capabilities, according to a statement released by the bank on Monday. No further details were provided regarding the financial terms of the transaction.

Focus on Medical Technology

MIV was founded in 1997 and initially managed the activities of the investment firm Microvalue, which specialized in medical technology. In 2008, this business was transitioned into the MIV Global Medtech Fund, as noted on the company’s website. The MIV team consists of experienced financial and medical technology analysts.

The acquiring bank describes the company as being known for its innovative approach and deep expertise in the sector.

J. Safra Sarasin anticipates growth in the medtech sector, citing factors such as an aging global population, technological innovation, the increase in chronic diseases, and expanded access to healthcare services in emerging markets. Additionally, applications leveraging artificial intelligence (AI) are seen as offering highly attractive long-term opportunities.